Related references
Note: Only part of the references are listed.TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer
Brian D. Lehmann et al.
CLINICAL CANCER RESEARCH (2020)
Selective androgen receptor modulators: the future of androgen therapy?
Andrew R. Christiansen et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2020)
Improved Synthesis and Determination of the Biologically Active Diastereomer of YK11
Yuichiro Kanno et al.
MOLBANK (2020)
Comparison of the three SARMs RAD-140, GLPG0492 and GSK-2881078 in two different in vitro bioassays, and in an in silico androgen receptor binding assay
Oliver Zierau et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)
Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells Through AR/Src/PI3-K Complex Assembly
Pia Giovannelli et al.
SCIENTIFIC REPORTS (2019)
Androgen Receptor Is a Non-canonical Inhibitor of Wild-Type and Mutant Estrogen Receptors in Hormone Receptor-Positive Breast Cancers
Suriyan Ponnusamy et al.
ISCIENCE (2019)
Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications
Zachary J. Solomon et al.
SEXUAL MEDICINE REVIEWS (2019)
Selective Androgen Receptor Modulator, YK11, Up-Regulates Osteoblastic Proliferation and Differentiation in MC3T3-E1 Cells
Tomofumi Yatsu et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2018)
Detection of SARMs in doping control analysis
Mario Thevis et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Development of selective androgen receptor modulators (SARMs)
Ramesh Narayanan et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Testosterone Deficiency and Testosterone Treatment in Older Men
Farid Saad et al.
GERONTOLOGY (2017)
CLDN8, an androgen-regulated gene, promotes prostate cancer cell proliferation and migration
Daisaku Ashikari et al.
CANCER SCIENCE (2017)
Enantioselective Allylic C-H Oxidation of Terminal Olefins to Isochromans by Palladium(II)/Chiral Sulfoxide Catalysis
Stephen E. Ammann et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Androgen receptor: structure, role in prostate cancer and drug discovery
M. H. Eileen Tan et al.
ACTA PHARMACOLOGICA SINICA (2015)
SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer
Diego Iglesias-Gato et al.
CARCINOGENESIS (2014)
Nigramide C Is a Natural Agonist of Human Pregnane X Receptor
Yuichiro Kanno et al.
DRUG METABOLISM AND DISPOSITION (2014)
Selective Androgen Receptor Modulator, YK11, Regulates Myogenic Differentiation of C2C12 Myoblasts by Follistatin Expression
Yuichiro Kanno et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2013)
Dynamics of Nuclear Receptor Helix-12 Switch of Transcription Activation by Modeling Time-Resolved Fluorescence Anisotropy Decays
Mariana R. B. Batista et al.
BIOPHYSICAL JOURNAL (2013)
Understanding nuclear receptor form and function using structural biology
Fraydoon Rastinejad et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2013)
Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters
James J. P. Stewart
JOURNAL OF MOLECULAR MODELING (2013)
Role of WNT7B-induced Noncanonical Pathway in Advanced Prostate Cancer
Dali Zheng et al.
MOLECULAR CANCER RESEARCH (2013)
An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity
Nicole L. Moore et al.
ENDOCRINE-RELATED CANCER (2012)
(17α,20E)-17,20-[(1-Methoxyethylidene)bis(oxy)]-3-oxo-19-norpregna-4,20-diene-21-carboxylic Acid Methyl Ester (YK11) Is a Partial Agonist of the Androgen Receptor
Yuichiro Kanno et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
Min Ni et al.
CANCER CELL (2011)
Identification of SRC3/AIB1 as a Preferred Coactivator for Hormone-activated Androgen Receptor
X. Edward Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Empirical Scoring Functions for Advanced Protein-Ligand Docking with PLANTS
Oliver Korb et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Testosterone and Growth Hormone Improve Body Composition and Muscle Performance in Older Men
Fred R. Sattler et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers
Harri Makkonen et al.
NUCLEIC ACIDS RESEARCH (2009)
Crystal structure of the T877A human androgen receptor ligand-binding domain complexed to cyproterone acetate provides insight for ligand-induced conformational changes and structure-based drug design
Casey E. Bohl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A role of the amino-terminal (N) and carboxyl-terminal (C) interaction in binding of androgen receptor to chromatin
JW Li et al.
MOLECULAR ENDOCRINOLOGY (2006)
Direct, androgen receptor-mediated regulation of the FKBP5 gene via a distal enhancer element
JA Magee et al.
ENDOCRINOLOGY (2006)
Androgen mediated regulation and functional implications of FKBP51 expression in prostate cancer
PG Febbo et al.
JOURNAL OF UROLOGY (2005)
Functional analysis of a novel androgen receptor mutation, Q902K, in an individual with partial androgen insensitivity
A Umar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
A bioinformatics-based functional analysis shows that the specifically androgen-regulated gene SARG contains an active direct repeat androgen response element in the first intron
K Steketee et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2004)
Improved protein-ligand docking using GOLD
ML Verdonk et al.
PROTEINS-STRUCTURE FUNCTION AND GENETICS (2003)
Expression and degradation of androgen receptor: Mechanism and clinical implication
DK Lee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
The nuclear receptor superfamily
M Robinson-Rechavi et al.
JOURNAL OF CELL SCIENCE (2003)
Dependence of selective gene activation on the androgen receptor NH2- and COOH-terminal interaction
B He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone
JS Sack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
